loadpatents
Patent applications and USPTO patent grants for Gazzard; Lewis.The latest application filed is for "tdo2 inhibitors".
Patent | Date |
---|---|
TDO2 Inhibitors App 20220306635 - Lin; Xingyu ;   et al. | 2022-09-29 |
Azaindoles As Inhibitors Of Hpk1 App 20210299110 - HEFFRON; Timothy ;   et al. | 2021-09-30 |
Naphthyridines as inhibitors of HPK1 Grant 11,034,692 - Chan , et al. June 15, 2 | 2021-06-15 |
Isoquinolines As Inhibitors Of Hpk1 App 20210163417 - Chan; Bryan ;   et al. | 2021-06-03 |
Azaindoles as inhibitors of HPK1 Grant 10,952,995 - Heffron , et al. March 23, 2 | 2021-03-23 |
TDO2 Inhibitors Grant 10,800,780 - Lin , et al. October 13, 2 | 2020-10-13 |
Piperidine derivatives as inhibitors of ubiquitin specific protease 7 Grant 10,766,903 - O'Dowd , et al. Sep | 2020-09-08 |
TDO2 and IDO1 Inhibitors App 20200216456 - Pei; Zhonghua ;   et al. | 2020-07-09 |
TDO2 and IDO1 Inhibitors App 20200123163 - Pei; Zhonghua ;   et al. | 2020-04-23 |
Azaindoles As Inhibitors Of Hpk1 App 20200000780 - HEFFRON; Timothy ;   et al. | 2020-01-02 |
Naphthyridines as inhibitors of HPK1 Grant 10,407,424 - Chan , et al. Sept | 2019-09-10 |
Piperidine Derivatives As Inhibitors Of Ubiquitin Specific Protease 7 App 20190256518 - O'DOWD; Colin ;   et al. | 2019-08-22 |
TDO2 Inhibitors App 20190016726 - Lin; Xingyu ;   et al. | 2019-01-17 |
Serine/threonine kinase inhibitors Grant 10,154,995 - Blake , et al. Dec | 2018-12-18 |
Naphthyridines As Inhibitors Of Hpk1 App 20180282328 - Chan; Bryan ;   et al. | 2018-10-04 |
Isoquinolines As Inhibitors Of Hpk1 App 20180282282 - Chan; Bryan ;   et al. | 2018-10-04 |
Serine/threonine Kinase Inhibitors App 20170348310 - Blake; James F. ;   et al. | 2017-12-07 |
Serine/threonine kinase inhibitors Grant 9,763,942 - Blake , et al. September 19, 2 | 2017-09-19 |
Serine/threonine kinase inhibitors Grant 9,670,208 - Blake , et al. June 6, 2 | 2017-06-06 |
Serine/threonine Kinase Inhibitors App 20160303126 - Blake; James F. ;   et al. | 2016-10-20 |
Serine/threonine Kinase Inhibitors App 20160304519 - Blake; James F. ;   et al. | 2016-10-20 |
1,7-diazacarbazoles and methods of use Grant 9,440,976 - Dyke , et al. September 13, 2 | 2016-09-13 |
Serine/threonine kinase inhibitors Grant 9,388,171 - Blake , et al. July 12, 2 | 2016-07-12 |
1,7-diazacarbazoles And Methods Of Use App 20150328195 - Dyke; Hazel Joan ;   et al. | 2015-11-19 |
Substituted quinazolines as serine/threonine kinase inhibitors Grant 9,187,462 - Blake , et al. November 17, 2 | 2015-11-17 |
Quinazoline Compounds As Serine/threonine Kinase Inhibitors App 20150087664 - Blake; James F. ;   et al. | 2015-03-26 |
Methods Of Use Of Diazacarbazoles For Treating Cancer App 20150087630 - Chen; Huifen ;   et al. | 2015-03-26 |
1,7-diazacarbazoles And Methods Of Use App 20140171407 - Dyke; Hazel Joan ;   et al. | 2014-06-19 |
Serine/threonine Kinase Inhibitors App 20140066453 - Blake; Jim ;   et al. | 2014-03-06 |
Inhibitors Of Iap App 20120270886 - Koehler; Michael F. T. ;   et al. | 2012-10-25 |
IAP inhibitors Grant 8,247,557 - Koehler , et al. August 21, 2 | 2012-08-21 |
1,7-diazacarbazoles And Methods Of Use App 20110183938 - Dyke; Hazel Joan ;   et al. | 2011-07-28 |
Iap Inhibitors App 20090221630 - Koehler; Michael F.T. ;   et al. | 2009-09-03 |
Caspase Activated Prodrugs Therapy App 20070104719 - Carter; Paul J. ;   et al. | 2007-05-10 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.